Close Menu

cervical cancer

The contract includes a milestone of approval by the Chinese Food and Drug Agency within the next three years.

The test for cervical cancer screening previously received the IVD mark and US Food and Drug Administration approval on the Cobas 4800 system.

The test will be developed in Global Good labs and ported onto QuantuMDx's handheld molecular platform.

In Nature this week: Plasmodium genomes and evolution, novel developmental disorder loci, and more.

The Cancer Genome Atlas Research Network team uncovered new mutations and amplifications in their cohort of primary cervical cancers.

The firms will target 18 Latin American countries in three years, with the goal of creating a complete HPV diagnostics system for the region.

The firm is also pursuing ovarian cancer screening and head and neck cancer tests using methylation-specific PCR. 

The firm's PCR-based products for HPV-associated cancers look at DNA methylation at specific genes and include several sample preparation kits.

An evaluation of more than 5,000 women attending primary cervical cancer screening showed self-collection and physician-collected samples are comparable.

The UK firm anticipates CE marking shortly and will focus on the European and Chinese markets for its multiplex PCR test for human papillomavirus genotyping. 

Pages

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.